Anebulo Pharmaceuticals Files 8-K
Ticker: ANEB · Form: 8-K · Filed: Jul 22, 2024 · CIK: 1815974
| Field | Detail |
|---|---|
| Company | Anebulo Pharmaceuticals, Inc. (ANEB) |
| Form Type | 8-K |
| Filed Date | Jul 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.9 million, $0.9 million, $1 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, sec-filing
TL;DR
Anebulo filed an 8-K, check exhibits for any news.
AI Summary
Anebulo Pharmaceuticals, Inc. filed an 8-K on July 22, 2024, reporting other events and financial statements. The filing does not contain specific details about new material events, significant financial transactions, or executive changes, but it does include exhibits.
Why It Matters
This 8-K filing indicates that Anebulo Pharmaceuticals has submitted required disclosures to the SEC, which may contain updates or exhibits relevant to investors.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not appear to contain any immediately alarming information.
Key Players & Entities
- Anebulo Pharmaceuticals, Inc. (company) — Registrant
- July 22, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-40388 (filing_id) — Commission File Number
- 85-1170950 (tax_id) — IRS Employer Identification No.
- 1017 Ranch Road 620 South , Suite 107 Lakeway , TX 78734 (address) — Address of Principal Executive Offices
- (512) 598-0931 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing for Anebulo Pharmaceuticals, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of July 22, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 22, 2024.
What is Anebulo Pharmaceuticals, Inc.'s state of incorporation and IRS Employer Identification Number?
Anebulo Pharmaceuticals, Inc. is incorporated in Delaware and its IRS Employer Identification Number is 85-1170950.
Where are Anebulo Pharmaceuticals, Inc.'s principal executive offices located?
Anebulo Pharmaceuticals, Inc.'s principal executive offices are located at 1017 Ranch Road 620 South, Suite 107, Lakeway, TX 78734.
What is the Commission File Number for Anebulo Pharmaceuticals, Inc.?
The Commission File Number for Anebulo Pharmaceuticals, Inc. is 001-40388.
Filing Stats: 529 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-07-22 07:05:10
Key Financial Figures
- $1.9 million — ooperative grant of up to approximately $1.9 million from the National Institute on Drug Abu
- $0.9 million — two tranches with the initial award of $0.9 million and subsequent funding of approximately
- $1 million — and subsequent funding of approximately $1 million subject to certain milestones. The gran
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-028629.txt ( ) — 245KB
- aneb-20240722.xsd (EX-101.SCH) — 3KB
- aneb-20240722_lab.xml (EX-101.LAB) — 34KB
- aneb-20240722_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ANEBULO PHARMACEUTICALS, INC. Date: July 22, 2024 By: /s/ Richard Anthony Cunningham Richard Anthony Cunningham Chief Executive Officer ( Principal Executive Officer )